Applications of (S)-2-Aminobutyramide Hydrochloride in Industrial Manufacturing

(S)-2-Aminobutyramide Hydrochloride supports key processes in pharmaceutical synthesis, specialty intermediates, and advanced technology chemical manufacturing. As the original manufacturer, we ensure direct integration into high-value industries requiring fine chiral purity, strict compliance, and tailored input for specific downstream products.

1. Chiral Intermediate for Active Pharmaceutical Ingredient (API) Synthesis

Our material is used as a chiral building block in the synthesis of β-amino acid-containing pharmaceuticals and peptidomimetic drug substances. In these processes, precise chirality control is critical for downstream pharmacological efficacy and regulatory acceptance. Manufacturers introduce (S)-2-Aminobutyramide Hydrochloride in early to mid-stage synthesis routes, where its enantiomeric purity helps define the stereochemistry of the final API. Typical reaction sequences include amide bond formation, amidation, and chiral auxiliary transformations before downstream purification and formulation. Specific diseases targeted by finished APIs include central nervous system disorders and metabolic disease, where enantiomerically pure intermediates are a mandatory regulatory requirement.

Industry compliance standards

• ICH Q7 GMP for Active Pharmaceutical Ingredients
• United States Pharmacopeia (USP) standards for chiral intermediates
• European Pharmacopoeia (Ph. Eur.) requirements on starting materials
• FDA 21 CFR Part 210/211 for API quality controls in pharmaceuticals

Typical usage ratio

• Amounts range from 0.5–5 molar equivalents relative to the next chiral synthesis step, adjusted according to target API molecular weight and purity criteria

Downstream process integration

• Material enters the synthesis as an initial chiral source in the batch or flow reactor
• Participates in enantioselective transformations and chiral protection/deprotection cycles
• Subject to in-process analytical controls (e.g., HPLC enantiomeric purity)
• Isolated after synthetic step and used immediately or stored under controlled conditions

Final product types

• Enantiopure pharmaceutical APIs (e.g., anticonvulsants, antihypertensives, antidiabetic agents)
• Advanced pharmaceutical intermediates for peptide therapeutics
• Building blocks for branded generic medicines
• Stereochemically-defined contract manufactured APIs

2. Component in Peptide Synthesis for Biopharmaceuticals

This raw material serves as a non-proteinogenic amino acid source in the production of synthetic peptides for biopharmaceutical applications. Operators add (S)-2-Aminobutyramide Hydrochloride during solid-phase peptide synthesis (SPPS) and liquid-phase protocols where backbone modification at specific residue positions is required. By integrating the compound at select coupling cycles, chemists introduce stability and intended biological activity in peptide-based drug candidates, peptide vaccines, and diagnostic agents. Material handling protocols must ensure low moisture and controlled temperature for batch reproducibility.

Industry compliance standards

• ICH Q11 guidelines on drug substance development & manufacture
• EU EMA GMP Guidelines Part II: basic requirements for biopharmaceuticals
• USP General Chapter <1047> on peptide mapping/characterization
• ISO 9001:2015 system for batch and quality traceability

Typical usage ratio

• 0.05–0.2 mmol per resin loading in solid-phase peptide synthesis, adjusted per sequence requirements and resin capacity

Downstream process integration

• Added at defined coupling steps to introduce (S)-β-amino units
• Integrated using carbodiimide or acid chloride activation chemistry
• Monitored by on-line cleavage/deprotection and LC-MS QC
• Product proceeds to cleavage, purification (HPLC), and lyophilization

Final product types

• Therapeutic peptide drugs for oncology and metabolic disorders
• Engineered peptide APIs for specialty injectables
• Peptide-based diagnostic reagents
• Synthetic peptide vaccine candidates under clinical development

3. Precursor in Agrochemical Intermediate Synthesis

(S)-2-Aminobutyramide Hydrochloride is used as a chiral precursor during the manufacturing of key intermediates for crop protection actives. Agrochemical formulators utilize its amide moiety in multi-step synthesis when constructing heterocyclic rings or introducing nitrogen-bearing side chains that control activity and selectivity in target molecules. The focus remains on highly controlled batch chemistry, with close monitoring for impurities and scalable work-up procedures to enable consistent downstream formulation. Producers strictly observe residue levels to comply with environmental safety regulations.

Industry compliance standards

• FAO/WHO good laboratory practices (GLP) for agrochemical synthesis
• ISO 9001:2015 and ISO 14001:2015 for environmental management
• REACH registration obligations for new chemical introductions in EU
• OECD guidelines for chemical purity and residual solvent limits

Typical usage ratio

• Input at 0.8–2 equivalents, optimized based on target intermediate yield and downstream impurity profile

Downstream process integration

• Charged as the amide source early in construction of the agrochemical backbone
• Undergoes nucleophilic substitution and cyclization steps
• Batched with in-process GC and impurity analysis checkpoints
• Isolated intermediates feed into final active ingredient synthesis under inert conditions

Final product types

• Heterocyclic herbicide intermediates
• Chiral fungicide precursors
• Insecticide candidates for registration studies
• Pre-formulation raw materials for proprietary crop protection actives

4. Building Block for Advanced Materials and Specialty Polymers

In advanced material manufacture, this compound is introduced as a monomeric chiral modifier during synthesis of optically active polyamides and functional polymers. R&D and production teams use it to improve molecular orientation, enhance mechanical and thermal properties, and refine end-product biofunctionality. Typical uses include incorporation into polymerization reactors, often in combination with other aliphatic and aromatic diamines under precisely controlled conditions. Analytical monitoring of molecular weight and optical isomer ratio forms part of routine quality release testing, assuring batch-to-batch consistency for end-users in the electronics, filtration, and biomedical sectors.

Industry compliance standards

• ISO 10993 testing framework for biomedical device polymers
• RoHS and REACH regulations for electronics intermediates
• ASTM D7016 protocols for polymer structural analysis
• Internal corporate material specification standards for high-performance polymers

Typical usage ratio

• Added at 1–10% molar ratio to total monomer feed, with adjustments based on target polymer properties and application sector

Downstream process integration

• Fed directly into condensation polymerization reactions with other monomers
• Integrated online gravimetric dosing and agitation controls
• Polymer melt or solution-phase processed and pelletized
• Final quality control using FTIR, GPC, and chiral HPLC methods

Final product types

• High-strength polyamide films for electronics
• Biocompatible polymers for medical devices and drug delivery systems
• Specialty filtration media
• Custom-engineered materials for advanced composites manufacturing